Search Results

Inside Moderna's plan to make billions from its 'superjab'

• Authors : By:Jared Lynch

• Source: Australian, The: Web Edition Articles (Australia), October 5, 2023 The Australian Business Network, 5pp

Record details

CSL warming to idea of a heat-tolerant Covid vaccine as cold storage limits effectiveness

• Authors : By:JARED LYNCH

• Source: Australian, The: Web Edition Articles (Australia), October 19, 2021 The Australian Business Network, 5pp

Record details

CSL plans to build $1.8bn vaccine factory in Melbourne's north

• Authors : By:Jared Lynch

• Source: Australian, The: Web Edition Articles (Australia), November 16, 2020 Companies, 3pp

Record details

Mercado de Vacunas contra la Gripe de los Estados Unidos 2020 – Análisis, Tamaño, Acción, Estrategias y Pronóstico de la Industria para 2027

• Authors : By:ICN Wiseguysreports

• Source: iCrowdNewswire: Spanish (USA), August 25, 2020 News, 11pp

Record details

Marché des vaccins antigrippaux des États-Unis 2020 – Analyse de l’industrie, taille, part, stratégies et prévisions pour 2027

• Authors : By:ICN Wiseguysreports

• Source: iCrowdNewswire: French (USA), August 25, 2020 News, 11pp

Record details

United States Influenza Vaccines Market 2020 – Branchenanalyse, Größe, Anteil, Strategien und Prognose bis 2027

• Authors : By:ICN Wiseguysreports

• Source: iCrowdNewswire: German (USA), August 25, 2020 News, 10pp

Record details

Mercado de Vacinas contra a Gripe dos Estados Unidos 2020 – Análise da indústria, tamanho, participação, estratégias e previsão para 2027

• Authors : By:ICN Wiseguysreports

• Source: iCrowdNewswire: Portuguese (USA), August 25, 2020 News, 11pp

Record details

United States Influenza Vaccines Market 2020 – Industry Analysis, Size, Share, Strategies and Forecast To 2027

• Authors : By:wiseguyreports

• Source: iCrowdNewswire (USA), August 25, 2020 News, 9pp

Record details

VaxInnate completes patient enrolment in VAX2012Q Phase I influenza vaccine trial.

• Source: Chemical Business NewsBase (UK), November 12, 2014, 1pp

Record details

Eurocine Vaccines announces initiation of clinical study of the nasal influenza vaccine candidate Immunose FLU.

• Source: Chemical Business NewsBase (UK), October 24, 2016, 1pp

Record details